Iguchi Aiko, Mochiduki Yukako, Akiyama Hitoshi, Kamiya Hisashi, Xuan Xuenan
Veterinary Laboratory Medicine, Faculty of Agriculture, Tottori University, Tottori, Japan.
Itou Aigo Animal Clinic, Shizuoka, Japan.
J Vet Med Sci. 2025 May 15;87(5):532-535. doi: 10.1292/jvms.24-0443. Epub 2025 Apr 4.
There are various treatments have been reported for canine babesiosis. However, treatment methods that can eliminate the parasites have not been established. The current study aimed to evaluate the therapeutic effects of tafenoquine against natural Babesia gibsoni infection. In total, seven dogs with canine babesiosis and one dog with canine babesiosis not controlled with diminazene aceturate were included. Oral tafenoquine at dose of 10-20 mg/kg was administered orally on days 0 and 7. The hematocrit level and platelet count of the dogs were measured. The clinical symptoms of all dogs rapidly improved. Two dogs relapsed. However, their symptoms improved after two more doses of tafenoquine. Although recurrence could not be prevented, tafenoquine might be a treatment against canine babesiosis.
已有多种治疗犬巴贝斯虫病的方法被报道。然而,能够消除寄生虫的治疗方法尚未确立。当前研究旨在评估tafenoquine对犬自然感染吉氏巴贝斯虫的治疗效果。总共纳入了7只患有犬巴贝斯虫病的犬以及1只使用乙酰马嗪未能控制病情的患有犬巴贝斯虫病的犬。在第0天和第7天口服剂量为10 - 20 mg/kg 的tafenoquine。测量了这些犬的血细胞比容水平和血小板计数。所有犬的临床症状迅速改善。2只犬复发。然而,在再服用两剂tafenoquine后它们的症状有所改善。尽管无法预防复发,但tafenoquine可能是一种治疗犬巴贝斯虫病的方法。